Literature DB >> 30120606

Candidate gene sequencing reveals mutations causing hypoplastic amelogenesis imperfecta.

Youn Jung Kim1, Figen Seymen2, Jenny Kang3, Mine Koruyucu2, Nuray Tuloglu4, Sule Bayrak4, Elif Bahar Tuna2, Zang Hee Lee5, Teo Jeon Shin3, Hong-Keun Hyun3, Young-Jae Kim3, Sang-Hoon Lee3, Jan Hu6, James Simmer6, Jung-Wook Kim7,8.   

Abstract

OBJECTIVE: Amelogenesis imperfecta (AI) is a rare hereditary disorder affecting the quality and quantity of the tooth enamel. The purpose of this study was to identify the genetic etiology of hypoplastic AI families based on the candidate gene approach.
MATERIALS AND METHODS: We recruited three Turkish families with hypoplastic AI and performed a candidate gene screening based on the characteristic clinical feature to find the pathogenic genetic etiology.
RESULTS: The candidate gene sequencing of the LAMB3 gene for family 1 revealed a heterozygous nonsense mutation in the last exon [c.3431C > A, p.(Ser1144*)]. FAM20A gene sequencing for families 2 and 3 identified a homozygous deletion [c.34_35delCT, p.(Leu12Alafs*67)] and a homozygous deletion-insertion (c.1109 + 3_1109 + 7delinsTGGTC) mutation, respectively.
CONCLUSION: The candidate gene approach can be successfully used to identify the genetic etiology of the AI in some cases with characteristic clinical features. CLINICAL RELEVANCE: Identification of the genetic etiology of the AI will help both the family members and dentist understand the nature of the disorder. Characteristic clinical feature can suggest possible genetic causes.

Entities:  

Keywords:  Amelogenesis imperfecta; Candidate gene sequencing; Deletion-insertion mutation; FAM20A; LAMB3; Nonsense mutation

Year:  2018        PMID: 30120606      PMCID: PMC6378126          DOI: 10.1007/s00784-018-2577-9

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  1 in total

1.  The gain-of-function FAM83H mutation caused hypocalcification amelogenesis imperfecta in a Chinese family.

Authors:  Yingchun Zheng; Ting Lu; Jianfan Chen; Meiyi Li; Jun Xiong; Fei He; Zhongzhi Gan; Yingying Guo; Leitao Zhang; Fu Xiong
Journal:  Clin Oral Investig       Date:  2020-10-02       Impact factor: 3.573

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.